US Stock MarketDetailed Quotes
CLPT ClearPoint Neuro
- 15.750
- -0.730-4.43%
Close Dec 27 16:00 ET
- 15.490
- -0.260-1.65%
Post 20:01 ET
434.46MMarket Cap-22.83P/E (TTM)
16.435High15.660Low139.89KVolume16.230Open16.480Pre Close2.22MTurnover0.55%Turnover RatioLossP/E (Static)27.58MShares17.47052wk High14.99P/B400.44MFloat Cap5.10552wk Low--Dividend TTM25.42MShs Float31.290Historical High--Div YieldTTM4.70%Amplitude2.860Historical Low15.876Avg Price1Lot Size
ClearPoint Neuro Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 33.24%-1.2M | 47.43%-2.67M | 32.39%-3.84M | 15.14%-13.72M | 61.86%-1.17M | 53.37%-1.8M | -1.89%-5.08M | -33.05%-5.68M | -27.33%-16.17M | 13.71%-3.07M |
| Net income from continuing operations | -3.43%-4.97M | 37.49%-4.41M | 26.08%-4.15M | -34.40%-22.09M | -5.34%-4.62M | -26.95%-4.81M | -63.89%-7.05M | -41.68%-5.61M | -14.05%-16.44M | -5.69%-4.39M |
| Depreciation and amortization | 17.02%495K | 36.58%463K | 74.91%474K | 87.52%1.46M | 177.12%424K | 148.82%423K | 44.26%339K | 23.74%271K | 12.28%777K | -14.53%153K |
| Other non cash items | 57.14%22K | 132.56%14K | 127.27%15K | 69.87%-69K | 113.51%15K | 111.48%14K | -377.78%-43K | -523.08%-55K | -153.88%-229K | -265.67%-111K |
| Change In working capital | 149.36%1.35M | 30.36%-172K | 12.69%-1.54M | 91.70%-356K | 749.62%1.11M | 145.06%543K | 86.54%-247K | -27.90%-1.77M | -154.69%-4.29M | 121.62%131K |
| -Change in receivables | -441.89%-401K | -49.01%-602K | 559.78%846K | -754.98%-1.8M | -248.12%-1.14M | -489.47%-74K | 65.05%-404K | -218.71%-184K | 67.93%-211K | 305.79%771K |
| -Change in inventory | 346.15%754K | -155.51%-373K | 109.17%53K | 128.18%1.25M | 189.12%983K | 111.03%169K | 174.17%672K | 34.32%-578K | -157.93%-4.42M | -6.88%-1.1M |
| -Change in prepaid assets | -43.74%382K | -15.91%-459K | 492.86%165K | 90.71%-113K | -436.36%-354K | 585.00%679K | 65.20%-396K | -132.81%-42K | -360.61%-1.22M | -119.70%-66K |
| -Change in payables and accrued expense | 187.31%647K | 144.76%1.66M | 2.92%-931K | -140.79%-649K | 11.31%374K | -228.65%-741K | -50.62%677K | -38.58%-959K | 23.81%1.59M | 352.63%336K |
| -Change in other current assets | -102.13%-1K | --0 | ---39K | 466.67%22K | --0 | 4,600.00%47K | ---25K | --0 | 90.91%-6K | 2.63%-37K |
| -Change in other current liabilities | 10.00%-234K | -56.46%-230K | -17.12%-171K | -39.56%-755K | -43.26%-202K | -87.05%-260K | -10.53%-147K | -14.06%-146K | -25.23%-541K | -17.50%-141K |
| -Change in other working capital | -71.37%207K | 73.56%-165K | -1,116.67%-1.46M | 229.51%1.7M | 291.91%1.45M | 7,130.00%723K | -591.34%-624K | 1,957.14%144K | 212.12%515K | 93.23%371K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 33.24%-1.2M | 47.43%-2.67M | 32.39%-3.84M | 15.14%-13.72M | 61.86%-1.17M | 53.37%-1.8M | -1.89%-5.08M | -33.05%-5.68M | -27.33%-16.17M | 13.71%-3.07M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 94.89%-12K | 0 | 0 | 183.36%8.95M | -101.60%-188K | 62.76%-235K | 143.89%9.51M | 25.41%-138K | -6,290.48%-10.74M | 31,010.53%11.75M |
| Net PPE purchase and sale | 94.89%-12K | --0 | --0 | -183.40%-717K | 46.15%-21K | -240.58%-235K | -325.00%-323K | -100.00%-138K | -50.60%-253K | -2.63%-39K |
| Net intangibles purchase and sale | --0 | ---- | ---- | 62.60%-334K | 22.33%-167K | --0 | ---- | ---- | ---893K | ---215K |
| Net investment purchase and sale | --0 | ---- | ---- | 204.28%10M | --0 | --0 | ---- | ---- | ---9.59M | --12M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 94.89%-12K | --0 | --0 | 183.36%8.95M | -101.60%-188K | 62.76%-235K | 143.89%9.51M | 25.41%-138K | -6,290.48%-10.74M | 31,010.53%11.75M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -10,956.04%-10.06M | -32.49%160K | 321,160.00%16.05M | -27.63%296K | -30.18%155K | 72.34%-91K | -53.80%237K | -266.67%-5K | -99.13%409K | 362.50%222K |
| Net common stock issuance | --0 | --0 | --16.18M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | -8.28%288K | --21K | -32.08%506K | -13.51%192K | --0 | -38.79%314K | --0 | 8.13%745K | 111.43%222K |
| Net other financing activities | 32.97%-61K | -66.23%-128K | -2,920.00%-151K | 37.50%-210K | ---37K | ---91K | ---77K | ---5K | 43.91%-336K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -10,956.04%-10.06M | -32.49%160K | 321,160.00%16.05M | -27.63%296K | -30.18%155K | 72.34%-91K | -53.80%237K | -266.67%-5K | -99.13%409K | 362.50%222K |
| Net cash flow | ||||||||||
| Beginning cash position | 24.11%32.85M | 62.23%35.35M | -16.20%23.14M | -48.96%27.62M | 30.09%24.34M | 12.50%26.46M | -56.12%21.79M | -48.96%27.62M | 169.21%54.11M | -67.54%18.71M |
| Current changes in cash | -431.20%-11.27M | -153.68%-2.51M | 309.74%12.21M | 83.11%-4.48M | -113.50%-1.2M | 55.90%-2.12M | 117.88%4.67M | -30.82%-5.82M | -177.90%-26.49M | 351.36%8.9M |
| End cash Position | -11.38%21.57M | 24.11%32.85M | 62.23%35.35M | -16.20%23.14M | -16.20%23.14M | 30.09%24.34M | 12.50%26.46M | -56.12%21.79M | -48.96%27.62M | -48.96%27.62M |
| Free cash flow | 40.37%-1.21M | 52.06%-2.67M | 34.00%-3.84M | 14.68%-14.77M | 59.11%-1.36M | 54.70%-2.03M | -10.05%-5.57M | -30.62%-5.82M | -34.57%-17.31M | 7.55%-3.32M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data
